Hims & Hers Health (HIMS) Cash & Equivalents (2019 - 2026)

Hims & Hers Health (HIMS) has 8 years of Cash & Equivalents data on file, last reported at $222.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 18.8% year-over-year to $222.3 million; the trailing twelve-month figure through Mar 2026 stood at $222.3 million (down 18.8% YoY), and the FY2025 full-year result was $228.6 million, up 3.64% from the prior year.
• Cash & Equivalents retreated to $222.3 million in Q1 2026, from $228.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.1 billion in Q2 2025 to a low of $46.8 million in Q4 2022.
• A 5-year average of $193.7 million and a median of $105.2 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents sank 48.64% in 2022 and surged 769.78% in 2025, its largest moves.
• Tracing HIMS's Cash & Equivalents over 5 years: stood at $46.8 million in 2022, then soared by 106.67% to $96.7 million in 2023, then soared by 128.2% to $220.6 million in 2024, then climbed by 3.64% to $228.6 million in 2025, then decreased by 2.78% to $222.3 million in 2026.
• Business Quant data shows HIMS's Cash & Equivalents at $222.3 million in Q1 2026, $228.6 million in Q4 2025, and $345.8 million in Q3 2025.